Baker McKenzie Baker McKenzie
How Can We Help?
  • Home
  • Expertise
  • Healthcare & Life Sciences
Language:
English

Healthcare & Life Sciences

Purple loop
Insight | Thought Leadership

Data PULSE

Our Data PULSE platform helps you navigate the complex landscape of data, regulatory and IP protection concerns at each stage of the medical product life cycle.
Read More

Healthcare and life sciences are some of the largest and fastest-growing industries in the world, in addition to being the most regulated, with rapidly changing rules and regulations that often conflict from one country to another. Healthcare and life sciences companies face a number of challenges, including trying to understand how these laws impact their market and M&A strategies while contending with rising R&D costs, loss of patent protection of blockbuster drugs, pricing pressures, and competition from generics. Rapid convergence of the healthcare, life sciences and technology sectors requires even more legal expertise given the additional data privacy and intellectual property concerns.

Visit InsightPlus for our latest legal updates covering Healthcare & Life Sciences developments across the globe

Insight | Handbook
Ukrainian Laws in Wartime
Our guide provides an overview of the key features of wartime legislation.
Insight | Handbook
European Recovery Plan
Explore an overview of industry-specific opportunities arising from Member States' Recovery and Resilience Plans.
Insight | Thought Leadership
Data PULSE
Our Data PULSE platform helps you navigate the complex landscape of data, regulatory and IP protection concerns at each stage of the medical product life cycle.
Insight | Handbook
Doing Business in Peru 2022
The topics covered in this guide range from the promotion of private investment and tax regimes, to the general framework of the most important sectors in Peru.
Insight | Handbook
New Chambers Life Sciences Practice Guide 2022
As the global editor, we introduce this year's guide offering commentary on a wide range of legal and business issues in major healthcare and life sciences markets.
Insight | Thought Leadership
Life Sciences Business Evolution Series
Explore how pharma biotech, medical devices and medtech companies plan to evolve their business models, shaping the future of the life sciences ecosystem.
Insight | Podcast
Tax and Legal Implications of New Supply Chain Challenges
Understanding the importance of taxes in a company’s supply chain strategy is key to developing sustainable solutions. Learn the tax issues and trends in our video series.
Insight | Thought Leadership
More Aggressive Scrutiny of Life Science Deals - But Is There a Problem That Needs Solving?
Fiona Carlin, Anthony Gamble, Dan Graulich and Yana Ermak consider the justifications for this tougher approach and explore the potential chilling effect it might have.
Insight | Legal Update
Foreign Investment Screening and Healthcare
What are the implications of the new NSI Act regime and the Government's "public health emergencies" powers for healthcare and life sciences transactions?
Insight | Thought Leadership
Risk Reshaped: Tax Disputes Outlook 2022–2025
This report combines survey results from tax leaders in 10 jurisdictions and six sectors and insights from our tax disputes lawyers. 
Insight | Thought Leadership
The Future of Capital Raising in Biotech and Pharma
Despite a decline in overall global activity, the biopharma sectors continue to perform strongly, bolstered by several factors. 
View All Insight
News | Deal Announcement
Three victories for Baker McKenzie, with Goisis and Allena, in Rome, Palermo and Naples for Bio-Rad Laboratories in the immunohematology sector
Bio-Rad Laboratories, assisted by Baker McKenzie, celebrated three wins in Naples, Rome and Palermo.
News | Firm News
Baker McKenzie is expanding its partnership in Switzerland and worldwide
Three new partners in Switzerland and 116 new partners worldwide  
News | Deal Announcement
Baker McKenzie advises Galapagos on its acquisition of CellPoint and AboundBio
Both acquisitions will accelerate Galapagos' access to next generation cell therapies, significantly broaden their portfolio and will serve to position Galapagos in the next-generation cancer ...
News | Firm News
Baker McKenzie Ranked in Chambers USA 2022, with 41 Practice Groups and 79 Lawyers Recognized
Baker McKenzie recorded an increase in practice and lawyer rankings in the Chambers USA 2022 Guide, with 41 practice group rankings and 79 lawyer rankings, up from 39 and 70, respectively, in 2021.
News | Firm News
Africa Rising - quotes in celebration of Africa Day
Baker McKenzie partners and our African Relationship Firm colleagues share some of their thoughts on the many opportunities that the continent offers.
News | Deal Announcement
Baker McKenzie Advises Bristol Myers Squibb on Sale of Manufacturing Facility to LOTTE
Baker McKenzie advised Bristol Myers Squibb (BMS) on the sale of its manufacturing facility in East Syracuse, New York to LOTTE
News | Deal Announcement
Baker McKenzie Advised Bristol Myers Squibb in Strategic Collaboration with Amphista Therapeutics
Firm advised Bristol Myers Squibb in a strategic collaboration and license agreement with Amphista.
News | Firm News
Baker McKenzie Thailand provided pro bono advice to sports and doping agencies to align Doping Control in Sport Act
The alignment was a success, which led to the removal of Thailand from WADA's non-compliant list.
News | Awards
Best Lawyers recognizes Baker McKenzie lawyers in Australia
Sydney-based partner, Caroline Ho, was awarded Lawyer of the Year for Hospitality and Tourism Law with the highest overall peer-feedback.
News | Insight
Life Sciences Business Evolution Series: Shaping Growth – Supply Chains, Manufacturing & Collaboration
Companies looking for new destinations for manufacturing and supply chain operations rank the United States, China and Japan as the top three jurisdictions of interest.
News | Deal Announcement
Baker McKenzie advises Kerry Group plc on the acquisition of c-LEcta
Baker McKenzie has advised Kerry Group plc (“Kerry”), the global taste and nutrition company on the acquisition of approx. 93% of c-LEcta GmbH.
View All News
Events | Upcoming Webinar
Global Healthcare & Life Sciences Webinar Series
Our Global Healthcare & Life Sciences Webinar Series aims to share legal industry insights and provide practical guidance in the context of today's evolving world.
Events | Upcoming Webinar
Asia Pacific Competition Spotlight
Our new series explores sector-specific competition law and business challenges faced by legal counsel and business leaders in Asia Pacific.
View All Events

Ranked in the Top 10 Law Firms in the world for Life Sciences, Chambers Global

Americas

  • Ranked in Healthcare: Pharmaceutical/Medical Products Regulatory, Chambers USA 2022 (District of Columbia)
  • FDA Regulatory Firm to Watch, LMG Life Sciences Awards 2021 and 2020 (US)
  • Licensing and Collaborations Recommended Firm,  LMG Life Sciences 2021 and 2020 (US)
  • Financial & Corporate Firm to Watch, LMG Life Sciences Awards 2019 (US)
  • Band 1 for Life Sciences, Chambers Latin America 2021 (Mexico)
  • Band 2 for Life Sciences, Chambers Latin America 2021 (Peru)
  • Tier 1 for Life Sciences and Healthcare, Legal 500 Latin America 2022 (Argentina)
  • Tier 1 for Life Sciences, Legal 500 Latin America 2022 (Mexico)
  • Tier 2 for Life Sciences, Legal 500 Latin America 2022 (Colombia)

Europe, Middle East and Africa

  • Regulatory Firm of the Year, LMG Life Sciences EMEA 2022 (Turkey) - Esin Attorney Partnership (a Member Firm of Baker McKenzie International)
  • Turkey Firm of the Year, LMG Life Sciences EMEA 2022 (Turkey) - Esin Attorney Partnership (a Member Firm of Baker McKenzie International)
  • Impact Deal - Vifor Pharma / Sanifit, LMG Life Sciences EMEA 2022 (Turkey) - Esin Attorney Partnership (a Member Firm of Baker McKenzie International)
  • Band 1 for Life Sciences, Chambers Europe 2021 (Hungary and Russia)
  • Band 2 for Life Sciences, Chambers Europe 2021 (Germany and Spain)
  • Tier 1 for Healthcare & Life Sciences (Industry Focus and Regulatory), Legal 500 EMEA 2021 (Germany)
  • Tier 2 for Healthcare & Life Sciences (Industry Focus), Legal 500 EMEA 2021 (France, Italy, Spain)
  • Tier 2 for Healthcare & Life Sciences (Industry Focus), Legal 500 UK 2021 (London)
  • Law Firm of the Year for Health and Research, Top Legal Industry Awards (Italy)

Asia Pacific

  • Medical and Healthcare Law Firm of the Year, Asian Legal Business Southeast Asia Law Awards 2017 to 2021
  • Band 1 for Life Sciences, Chambers Global 2014 to 2021 and Chambers Asia Pacific 2014 to 2021
  • Band 2 for Life Sciences, Chambers Asia Pacific 2021 (Australia)
  • Band 2 for Life Sciences (International Firms), Chambers Asia Pacific 2021 (China)
  • Tier 1 for Healthcare and Life Sciences (Foreign Firms), Legal 500 Asia Pacific 2021 (China)

How We Can Help

Explore Healthcare & Life Sciences

HLS Hub

Healthcare & Life Sciences Hub

Stay apprised on key market trends, risks, opportunities and legal issues through our dedicated resources hub.

FT Big Deal Series: The Healthtech Sector’s Spectacular Surge in SPACs and de-SPACS

A three minute video discussing how the pandemic triggered a significant rise in SPAC investments in the healthtech sector.


healthcare icons on blue backgrounc

Healthcare & Life Sciences Supply Chain Webinar Series 

Focuses on the trends, issues and opportunities along each stage of supply chain life cycle for healthcare and life sciences companies.

Guide to IPOs for Biotech and Pharma Companies

Biotech and pharma companies undertaking capital raisings can approach the world’s capital markets in various ways.


Global Healthcare & Life Sciences Webinar Series

Aims to share legal industry insights and provide practical guidance in the context of today's evolving world.
about-healthcare

About Us

Learn about our Global Healthcare & Life Sciences Industry Group in 5 minutes

Hyper-Hybridity

Explores trends and opportunities in digital health from the perspective of three key players in the ecosystem: healthcare and life sciences organizations, technology companies and investors
Life sciences

Life Sciences Collaborations: Key Considerations in the COVID-19 Era

A high-level guide that outlines a list of issues to consider in executing life sciences collaborations in the COVID-19 era

Healthcare MapApp

Access real-time information on the laws and regulations affecting the healthcare and life sciences industries in more than 50 countries

Clinical Trials Handbook

Outlines the legal framework governing clinical trials of medicinal products in 34 jurisdictions
Banner for Promoting Medical Products Handbook

Promoting Medical Products Globally

Understand legal developments and regulations related to ethical business interactions between medical companies and healthcare professionals in 35 countries

Key Contacts